Tags : Rare Neurological Diseases

DigiHealth Pharma

Boehringer Ingelheim Collaborates with Healx to Identify New Treatments for

Shots: BI and Healx team up to discover new indications targeting rare neurological diseases by harnessing Healx’s AI-based drug discovery platform, Healnet to advance BI’s pipeline The collaboration combines BI’s expertise for drug development, especially in rare neurological conditions with Healx’s AI-powered drug discovery platform. Healx will utilize its data analysis and technological capabilities to […]Read More